The Pap test is the most effective screening test for cervical cancer and is often part of a pelvic exam. Testing should start within 3 years of a woman beginning sexual intercourse, whatever age that may be, but no later than 21 years of age. The U.S. Preventive Services Task Force (USPSTF) strongly recommends screening for cervical cancer in women who have been sexually active and have a cervix.1
The American Cancer Society recommends the following screening schedule.2
Females who get the
HPV
vaccine
(What is a PDF document?) should get screened for cervical cancer on the same schedule
as everyone else.3
Experts agree that women who have had three normal Pap test results in the past 10 years may decide to stop screening after ages 65 to 70. You and your health professional can decide on the appropriate age to stop based on your medical history. Some risk factors that you will want to consider include:1
A hysterectomy is a surgical procedure in which the entire uterus is removed, usually including the cervix. Occasionally the cervix may be left intact (supracervical hysterectomy). You and your health professional can decide on the appropriate interval based on your medical history.
Women who have gone through menopause have an increased risk of false-positive Pap test results. For this reason, postmenopausal women with previous normal Pap tests may be advised to have Pap tests less frequently than every year.4
After any abnormal Pap test, your health professional will recommend follow-up to monitor the cell changes.
Cervical cells can be collected by several different methods during a Pap test. Some experts believe that the type of collection method can help determine how often screening should occur. Research on these collection methods continues.
For more information, see the topics Abnormal Pap Test, Cervical Cancer, and Pap Test.
Citations
U.S. Preventive Services Task Force (2003). Screening for cervical cancer: Summary of recommendations. Available online: http://www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr.pdf.
Saslow D, et al. (2002). American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA: A Cancer Journal for Clinicians, 52(6): 342–362.
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR–2): 1–24. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5602.pdf.
Sawaya GF, et al. (2000). The positive predictive value of cervical smears in previously screened postmenopausal women: The Heart and Estrogen/progestin Replacement Study (HERS). Annals of Internal Medicine, 133(12): 942–950.
| Author | Shannon Erstad, MBA/MPH |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Denele Ivins |
| Associate Editor | Pat Truman |
| Primary Medical Reviewer | Joy Melnikow, MD, MPH - Family Medicine |
| Specialist Medical Reviewer | Barbara S. Apgar, MD, MS - Family Medicine, Women's Health |
| Specialist Medical Reviewer | Ross Berkowitz, MD - Obstetrics and Gynecology |
| Last Updated | January 12, 2007 |